Precision Wealth Strategies’s Regeneron Pharmaceuticals REGN Stock Holding History

Precision Wealth Strategies’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-395	Closed	-$285K	–	108
2022 Q4	$285K	Hold	395	–	–	0.3%	72
2022 Q3	$291K	Sell	395 -3	-0.8%	-$1.89K	0.26%	87
2022 Q2	$240K	Sell	398 -6	-1%	-$3.9K	0.19%	115
2022 Q1	$282K	Sell	404 -54	-12%	-$34.2K	0.17%	132
2021 Q4	$289K	Buy	458 +85	+23%	+$52.3K	0.21%	107
2021 Q3	$226K	Buy	+373	New	+$232K	0.17%	112

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Precision Wealth Strategies's REGN Position: Q1 2023 in Review

Precision Wealth Strategies sold out of Regeneron Pharmaceuticals (REGN) in Q1 2023, closing a stake of 395 shares — an estimated $285K sold.

Precision Wealth Strategies first reported a position in REGN in Q3 2021 and held it in 6 quarters. The position peaked at $291K in Q3 2022. 1,191 funds tracked by Wall St. Rank hold REGN as of Q1 2023.

Precision Wealth Strategies reported no remaining Regeneron Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Precision Wealth Strategies sold 395 Regeneron Pharmaceuticals shares in Q1 2023, an estimated $285K.
Precision Wealth Strategies first reported a position in Regeneron Pharmaceuticals in Q3 2021 and held it in 6 quarters.
Precision Wealth Strategies's Regeneron Pharmaceuticals position peaked at $291K in Q3 2022.
1,191 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2023.

Based on Precision Wealth Strategies's 13F filing for Q1 2023, filed 4 May 2023.